CIK 0001528115
- Non-accelerated filer
- Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 275414423
- Phone
- +1 650-822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 6,912 shares at $2.92 ($20,183)
- 4 Open-market sale PRESIDENT AND CEO sold 5,021 shares at $2.95 ($14,812)
- 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 1,786 shares at $2.98 ($5,322)
- 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 1,425 shares at $2.99 ($4,261)
- 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 1,783 shares at $2.99 ($5,331)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise PRESIDENT AND CEO acquired 37,994 shares (option exercise)
- 4 Open-market buy Director bought 3,200 shares at $5.33 ($17,056)
- 4 Option exercise PRESIDENT AND CEO acquired 114,449 shares (option exercise)
- 4 Planned sale EVP & CHIEF INNOVATION OFFICER sold 5,408 shares at $7.41 ($40,073)
- 4 Open-market buy Director bought 3,200 shares at $5.97 ($19,104)
- 4 Planned sale EVP & CHIEF INNOVATION OFFICER sold 4,500 shares at $7.10 ($31,950)
- 4 Planned sale EVP & CHIEF INNOVATION OFFICER sold 5,500 shares at $6.16 ($33,880)
- 4 Planned sale EVP & CHIEF INNOVATION OFFICER sold 5,500 shares at $5.64 ($31,020)
- 4 Open-market buy Director bought 3,200 shares at $5.48 ($17,536)
- 4 Planned sale EVP & CHIEF INNOVATION OFFICER sold 5,500 shares at $5.95 ($32,725)
- 4 Open-market buy Director bought 3,200 shares at $6.24 ($19,968)
- 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 784 shares at $6.02 ($4,720)
- 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 1,104 shares at $6.03 ($6,657)
Page 4 of 11 · 206 filings